Cash and Cash Equivalents, at Carrying Value of Sonnet BioTherapeutics Holdings, Inc. from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • Sonnet BioTherapeutics Holdings, Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 30 Sep 2025 was $5,120,264, a 3326% increase year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,120,264 +$4,970,808 +3326% 30 Sep 2025 10-K 16 Dec 2025 2025 FY
Q3 2024 $149,456 -$2,124,803 -93% 30 Sep 2024 10-K 16 Dec 2025 2025 FY
Q3 2023 $2,274,259 30 Sep 2023 10-K 17 Dec 2024 2024 FY
Q1 2016 $1,178,000 -$2,146,569 -65% 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 $1,527,886 +$1,282,058 +522% 31 Dec 2015 10-Q 16 May 2016 2016 Q1
Q3 2015 $1,805,927 +$1,548,150 +601% 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 $2,808,181 +$2,550,404 +989% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 $3,324,569 +$2,889,416 +664% 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q4 2014 $245,828 -$196,866 -44% 31 Dec 2014 10-Q 16 May 2016 2016 Q1
Q3 2014 $257,777 +$44,548 +21% 30 Sep 2014 10-Q 16 Nov 2015 2015 Q3
Q2 2014 $257,777 +$97,227 +61% 30 Jun 2014 10-Q 14 Aug 2015 2015 Q2
Q1 2014 $435,153 +$45,805 +12% 31 Mar 2014 10-Q 20 May 2015 2015 Q1
Q4 2013 $442,694 -$781,109 -64% 31 Dec 2013 10-K 31 Mar 2016 2015 FY
Q3 2013 $213,229 -$1,465,205 -87% 30 Sep 2013 10-Q 14 Nov 2014 2014 Q3
Q2 2013 $160,550 -$3,386,904 -95% 30 Jun 2013 10-Q 14 Aug 2014 2014 Q2
Q1 2013 $389,348 +$172,680 +80% 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q4 2012 $1,223,803 +$1,058,674 +641% 31 Dec 2012 10-K 15 Apr 2015 2014 FY
Q3 2012 $1,678,434 +$1,454,577 +650% 30 Sep 2012 10-Q 15 Nov 2013 2013 Q3
Q2 2012 $3,547,454 +$3,545,583 +189502% 30 Jun 2012 10-Q 12 Aug 2013 2013 Q2
Q1 2012 $216,668 +$46,162 +27% 31 Mar 2012 10-Q 15 May 2013 2013 Q1
Q4 2011 $165,129 +$119,122 +259% 31 Dec 2011 10-K 31 Mar 2014 2013 FY
Q3 2011 $223,857 +$211,552 +1719% 30 Sep 2011 10-Q/A 31 Dec 2012 2012 Q3
Q2 2011 $1,871 -$19,923 -91% 30 Jun 2011 10-Q/A 02 Jan 2013 2012 Q2
Q1 2011 $170,506 31 Mar 2011 10-Q/A 28 Dec 2012 2012 Q1
Q4 2010 $46,007 31 Dec 2010 10-K 03 Apr 2013 2012 FY
Q3 2010 $12,305 30 Sep 2010 10-Q 14 Nov 2011 2011 Q3
Q2 2010 $21,794 30 Jun 2010 10-Q 15 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.